InspireMD Profit Margin

The latest profit margin for NSPR is -415.7% as of December 2025. That compares with -335.9% in the prior-year period — down 23.8% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside InspireMD's historical trend and sector peers before judging valuation or financial health.

Over the past year, NSPR's profit margin moved from -335.9% to -415.7% — a 23.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in InspireMD's valuation or profitability profile.

Against Healthcare companies, NSPR currently prints -415.7% for profit margin, while the sector average sits near 13.89%. That is roughly 3092.2% below the sector mean. Large gaps often invite a closer look at InspireMD's growth, margins, and balance sheet.

Profit Margin shows how effectively InspireMD converts resources into returns. At -415.7%, NSPR may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -335.9% in the prior-year period — down 23.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting NSPR's profit margin (-415.7%), review year-over-year change from -335.9%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.